Ms. Rydin (born 1957) holds a Master of Science degree from Chalmers University of Technology, Sweden. Ms. Rydin was elected to the Board in 2014. Her latest assignments have been as CEO of entrepreneurial companies in the Life Science and Health Care industry. Before this she was serving as VP Wound & Skin Care Global Marketing of Coloplast and Managing Director of the Mölnlycke Health Care subsidiary in Eastern Europe. Ms. Rydin started her career in SCA Hygiene / Mölnlycke in 1981 in Research & Development and has held a range of management positions in Marketing & Sales. Rydin holds no shares in Biotec Pharmacon.
Life Science and Health Care